BeiGene has a total of three marketed proprietary products.

FAST NEWS: Beigene stock falls after Novartis terminates partnership

The latest: Cancer drug maker BeiGene Ltd. (BGNE.US; 6160.HK; 668235.SH) announced Tuesday that Novartis (NOVN.SWX) will relinquish its rights to co-develop, produce and commercialize BeiGene’s esophagus cancer drug tislelizumab. Looking up: Novartis will provide…
BGNE.US 6160.HK
The latest IPO prospectus from FWD Group Holdings Ltd. lapsed early this month, further delaying the regional insurer’s listing after its fourth application.

FAST NEWS: FWD Group delays Hong Kong IPO plan again

The latest: The latest IPO prospectus from FWD Group Holdings Ltd. lapsed early this month, further delaying the regional insurer’s listing after its fourth application. The company decided to postpone its…
Online insurer ZhongAn Online P & C Insurance announced its aggregate gross written premiums in the first eight months of this year totaled about 20.7 billion yuan.

FAST NEWS: ZhongAn’s gross written premium growth slows

The latest: Online insurer ZhongAn Online P & C Insurance Co. Ltd. (6060.HK) announced Wednesday its aggregate gross written premiums in the first eight months of this year totaled about 20.7 billion yuan…
6060.HK